Canadian Exchanges Stock Scanner IMV Inc, IntelliPharmaCeutics International, OrganiGram Holdings, and Antibe Therapeutics

LONDON, UK / ACCESSWIRE / July 25, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equitiesfrom the Biotechnology industry: IMV Inc., IntelliPharmaCeutics International, OrganiGram Holdings, and Antibe Therapeutics. Access our complimentary up-to-the-minute research reports by becoming an online member now:

www.active-investors.com/registration-sg

The S&P/TSX Composite Index lost 30.71 points, or 0.19%, to close Tuesday's trading session at 16,390.13. The TSX Venture Exchange shaved off 3.89 points, or 0.55%, to finish at 706.42.

Moreover, the Healthcare index was down by 2.54%, closing at 89.89.

Today's stocks of interest consist of: IMV Inc. (TSX: IMV), IntelliPharmaCeutics International Inc. (TSX: IPCI), OrganiGram Holdings Inc. (TSX-V: OGI), and Antibe Therapeutics Inc. (TSX-V: ATE). Click the link below to view a sample of the free research report that will be available to you as a member of Active-Investors:

www.active-investors.com/registration-sg

IMV Inc.

On Tuesday, shares in Halifax, Canada-based IMV Inc. ended the session 0.78% higher at $6.45 with a total volume of 20,630 shares traded. IMV's shares have surged 11.80% in the last three months and 63.61% in the previous year. Shares of the Company, which together with its subsidiaries, develops products based on its platform and products with a primary focus on T cell activating therapies for cancer, are trading below its 50-day and 200-day moving averages. Furthermore, the stock's 50-day moving average of $6.84 is greater than its 200-day moving average of $6.72. View the research report on IMV.TO at:

www.active-investors.com/registration-sg/?symbol=IMV

IntelliPharmaCeutics International Inc.

Toronto, Canada-based IntelliPharmaCeutics International Inc.'s stock closed the day 2.33% lower at $0.42. The stock recorded a trading volume of 3,500 shares. Shares of the Company, which researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in Canada, are trading below their 50-day and 200-day moving averages. Moreover, the stock's 200-day moving average of $0.72 is greater than its 50-day moving average of $0.58. Get the free report on IPCI.TO at:

www.active-investors.com/registration-sg/?symbol=IPCI

OrganiGram Holdings Inc.

Moncton, Canada-based OrganiGram Holdings Inc.'s stock finished Tuesday's session 1.69% lower at $4.65 with a total volume of 532,552 shares traded. OrganiGram Holdings' shares have rallied 87.50% in the past year. Shares of the Company, which through its subsidiaries, produces and sells medical marijuana to individuals and physicians in Canada, are trading above its 200-day moving average. OrganiGram Holdings' 50-day moving average of $5.23 is above its 200-day moving average of $4.59. Access the most recent report coverage on OGI.V at:

www.active-investors.com/registration-sg/?symbol=OGI

Antibe Therapeutics Inc.

On Tuesday, shares in Toronto, Canada headquartered Antibe Therapeutics Inc. recorded a trading volume of 282,895 shares. The stock ended the day 4.62% lower at $0.31. Antibe Therapeutics' stock has rallied 244.44% in the past year. Shares of the Company, which together with its subsidiaries, originates, develops, and out-licenses patent protected pharmaceuticals primarily in Canada, Europe, and the US, are trading below its 50-day and 200-day moving averages. The stock's 50-day moving average of $0.38 is above its 200-day moving average of $0.35. Today's complimentary report on ATE.V can be accessed at:

www.active-investors.com/registration-sg/?symbol=ATE

Active-Investors:

Active-Investors (A-I) produces regular sponsoredand non-sponsored reports, articles, stock market blogs, and popular investmentnewsletters covering equities listed on NYSE and NASDAQ and Canadian stocks.A-I has two distinct and independent departments. One department producesnon-sponsored analyst certified content generally in the form of pressreleases, articles and reports covering equities listed on NYSE and NASDAQ andthe other produces sponsored content (in most cases not reviewed by aregistered analyst), which typically consists of compensated investmentnewsletters, articles and reports covering listed stocks and micro-caps. Suchsponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly orindirectly; for producing or publishing this document.

PRESS RELEASEPROCEDURES:

The non-sponsored content contained herein has beenprepared by a writer (the "Author") and is fact checked and reviewedby a third-party research service company (the "Reviewer")represented by a credentialed financial analyst [for further information onanalyst credentials, please email info@active-investors.com.Rohit Tuli, a CFA^® charterholder (the"Sponsor"), provides necessary guidance in preparing the documenttemplates. The Reviewer has reviewed and revised the content, as necessary,based on publicly available information which is believed to be reliable.Content is researched, written and reviewed on a reasonable-effort basis. TheReviewer has not performed any independent investigations or forensic audits tovalidate the information herein. The Reviewer has only independently reviewedthe information provided by the Author according to the procedures outlined byA-I. A-I is not entitled to veto or interfere in the application of suchprocedures by the third-party research service company to the articles,documents or reports, as the case may be. Unless otherwise noted, any contentoutside of this document has no association with the Author or the Reviewer inany way.

NO WARRANTY

A-I, the Author, and the Reviewer are notresponsible for any error which may be occasioned at the time of printing ofthis document or any error, mistake or shortcoming. No liability is acceptedwhatsoever for any direct, indirect or consequential loss arising from the useof this document. A-I, the Author, and the Reviewer expressly disclaim anyfiduciary responsibility or liability for any consequences, financial orotherwise arising from any reliance placed on the information in this document.Additionally, A-I, the Author, and the Reviewer do not (1) guarantee theaccuracy, timeliness, completeness or correct sequencing of the information, or(2) warrant any results from use of the information. The included informationis subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering,recommendation, or a solicitation of an offer to buy or sell the securitiesmentioned or discussed, and is to be used for informational purposes only.Please read all associated disclosures and disclaimers in full beforeinvesting. Neither A-I nor any party affiliated with us is a registeredinvestment adviser or broker-dealer with any agency or in any jurisdictionwhatsoever. To download our report(s), read our disclosures, or for moreinformation, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach outto us directly. If you're a company we are covering andwish to no longer feature on our coverage list contact us via email and/orphone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
OfficeAddress: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, WilayahPersekutuan Kuala Lumpur, Malaysia

SOURCE:Active-Investors